4//SEC Filing
RALLIS CHRIS A 4
Accession 0001185945-25-000005
CIK 0001211583other
Filed
Oct 13, 8:00 PM ET
Accepted
Oct 14, 4:10 PM ET
Size
8.9 KB
Accession
0001185945-25-000005
Insider Transaction Report
Form 4
RALLIS CHRIS A
Director
Transactions
- Sale
Common Shares
2025-10-10$9.24/sh−1,775$16,401→ 57,079 total - Exercise/Conversion
Common Shares
2025-10-10$1.23/sh−4,062$4,996→ 174,344 totalExercise: $1.23From: 2015-11-10Exp: 2025-11-10→ Options (4,062 underlying) - Exercise/Conversion
Common Shares
2025-10-10$1.23/sh+4,062$4,996→ 58,854 total
Footnotes (3)
- [F1]Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on May 19, 2025.
- [F2]Shares sold to satisfy tax obligation on option exercise.
- [F3]Represents options exercised pursuant to a 10b5-1 plan adopted on May 19, 2025.
Documents
Issuer
FENNEC PHARMACEUTICALS INC.
CIK 0001211583
Entity typeother
Related Parties
1- filerCIK 0001185945
Filing Metadata
- Form type
- 4
- Filed
- Oct 13, 8:00 PM ET
- Accepted
- Oct 14, 4:10 PM ET
- Size
- 8.9 KB